 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| Treatment Dependence upon substances such as alcohol, stimulants, cocaine, opiates including pain relievers and many other chemicals can contribute to long-term physical, social, occupational and financial problems—even death. It is important to take these problems seriously and to have trained addiction treatment professionals evaluate these problems. These problems are treatable. People do go on to recover their lives. There are new medication treatments available to help with chemical dependency, however medications should never be used alone—that is without the additional help of research-based treatment options. These options vary depending on each person’s needs. We can develop a treatment plan that matches your individual needs, problems and goals. Most, but not all, clinicians at CBT accept Medicare and most major insurance plans. We will help you to confirm your coverage prior to making an appointment. Please contact our business office to discuss your individual insurance and payment needs. We are open Monday through Friday 8:00 - 5:00 p.m. Please contact us for information on how to prepare for your first visit and what to bring with you to the Center. Contact our office for more information on Substance Recovery Options. Dr. Sharon Morgillo Freeman works in collaboration with Dr. Ronald Pancner to provide treatment for opiate dependence using researched based Cognitive Behavior Therapy and Medication management with Suboxone. Suboxone is a combination medication: Buprenorphine and Naltrexone. The National Institute of Drug Abuse (NIDA) supported basic and clinical research led to the development of buprenorphine, which culminated in a large NIDA-sponsored, multisite clinical trial demonstrating its effectiveness. The trial showed that, alone or in combination with naloxone, buprenorphine significantly reduced opiate drug abuse and cravings and was a safe and acceptable addiction treatment (figure). Link to website explaining Suboxone. The FDA approved Subutex® (buprenorphine) and Suboxone® tablets (buprenorphine/naloxone) in October 2002, making them the first medications to be eligible for prescribing under the DATA 2000. To date, nearly 10,000 physicians have taken the training needed to prescribe these two medications, and nearly 7,000 have registered as potential providers. Buprenorphine's Pioneering Contributions to Addiction Treatment Buprenorphine's novel formulation with naloxone, an opioid antagonist, limits abuse and diversion potential. Scientific breakthroughs led to this formulation, which produces severe withdrawal symptoms in those who inject it to get "high" but no adverse effects when taken orally, as prescribed. Buprenorphine represents a health services delivery innovation. The development of buprenorphine and its authorized use in physicians' offices gives opiate-addicted patients more medical options and extends the reach of addiction medication to remote populations. Its accessibility may even prompt earlier attempts to obtain treatment. According to the National Institute on Alcohol Abuse and Alcoholism, in contrast to many other therapies, cognitive-behavioral therapy for the treatment of substance abuse disorders has substantial research evidence in support of its effectiveness. Cognitive Behavior Therapy formed the basis for treatment in Project MATCH as conducted by NIAAA (National Institute on Alcohol Abuse and Alcoholism). The foundation for the CBT delivered in Project MATCH (Matching Alcohol Treatment to Client Heterogeneity Project) (Kadden et al., 1992), was a large multisite study of treatment matching funded by the (NIAAA). While the topics used in this particular example were developed for use with clients with alcohol abuse disorders, they are easily adapted to the needs of clients who are abusing other substances. |
| The Substance Recovery Program |
| CBT The Center for Brief Therapy, PC, 10319 Dawson's Creek Blvd, Suite J, Fort Wayne, Indiana, USA 46825 260-969-5583; fax 260-969-5584; email: freemancbt@aol.com |